Stock Report

All about this stock under one free report Last Updated: 30-Aug-2026

Stock Rating

Is this stock worth it? Our ratings reveal the truth.

Wealth Insight New Issue

Serious stock insights. No fluff. No FOMO.

Recently Viewed

Clear All

Clinitech Laboratory Key Ratios

Stock Card factsheet watchlist-stock-modal share-fund-plan-icon

BSE: 544220

₹36.60

up-down-arrow ₹1.60 (4.57%)

As on 28-Aug-2026IST

Market cap

info icon

₹8 Cr

Revenue (TTM)

info icon

₹8 Cr

P/E Ratio

info icon

20

P/B Ratio

info icon

--

Div. Yield

info icon

0 %

Key Ratios and Highlights

Growth Score (%) Quarterly Annual (TTM)
Particulars QoQ YoY 1-Year 3-Years 5-Years
Revenue -- -- 28.61 8.85 --
EBIT -- -- -31.95 -17.77 --
Net Profit -- -- 6.33 -8.34 --
EPS -- -- -21.73 -20.31 --
Book Value -- -- 83.19 46.44 --
Key Ratios (%) Average Annual (TTM)
Particulars3-Years5-YearsMar-25Mar-24Mar-23
EBIT-Margin info 9.29--4.648.7714.46
Net Margin info 6.69--4.665.769.63
Return on equity info 15.96--6.3812.5229.00
Return on Capital info 18.29--9.2115.2830.39
Return on Assets info 8.16--4.946.5612.97
Debt to Equity (x) info ----0.000.240.43

Profitability

View Detailed Peer Comparison

ROCE

9.21

Lower than Peers by 11.04

Earning before interest and taxes / (Average net worth + Average total Debt) * 100

Company Name
Mar-25
Mar-24
Mar-23
Mar-22
Mar-21
Clinitech Laboratory
9.21
15.28
30.39
32.61
32.47
Peer Median
20.26
19.83
33.53
37.00
--
ROE

6.38

Lower than Peers by 7.55

Profit after tax / Average Net worth * 100

Company Name
Mar-25
Mar-24
Mar-23
Mar-22
Mar-21
Clinitech Laboratory
6.38
12.52
29.00
31.66
28.94
Peer Median
13.93
15.80
26.65
26.85
--
ROA

4.94

Lower than Peers by 5.06

Profit after tax / Average Total assets * 100

Company Name
Mar-25
Mar-24
Mar-23
Mar-22
Mar-21
Clinitech Laboratory
4.94
6.56
12.97
16.47
15.21
Peer Median
10.00
8.30
16.54
17.58
--
EBIT Margin

4.64

Lower than Peers by 15.02

Operating profit (EBIT) / Net Sales * 100

Company Name
Mar-25
Mar-24
Mar-23
Mar-22
Mar-21
Clinitech Laboratory
4.64
8.77
14.46
10.77
12.81
Peer Median
19.66
18.70
19.68
25.18
--
Net Margin

4.66

Lower than Peers by 7.29

Net profit / Total Income (Net sales plus other income) * 100

Company Name
Mar-25
Mar-24
Mar-23
Mar-22
Mar-21
Clinitech Laboratory
4.66
5.76
9.63
7.94
8.75
Peer Median
11.96
12.26
16.78
18.16
--
Cash Profit Margin

10.26

--

(Net profit + Depreciation) / Gross Sales * 100

Company Name
Mar-25
Mar-24
Mar-23
Mar-22
Mar-21
Clinitech Laboratory
10.26
12.65
16.68
13.99
14.22
Peer Median
--
--
--
--
--

Growth

View Detailed Peer Comparison

Revenue Growth

28.61

Higher than Peers by 12.87

Year on year growth in net sales

Company Name
Mar-25
Mar-24
Mar-23
Mar-22
Mar-21
Clinitech Laboratory
28.61
0.87
-0.58
40.19
--
Peer Median
15.74
13.67
4.18
49.99
--
EBIT Growth

-31.95

Lower than Peers by 54.55

Year on year growth in operating profit (EBIT)

Company Name
Mar-25
Mar-24
Mar-23
Mar-22
Mar-21
Clinitech Laboratory
-31.95
-38.81
33.51
17.81
--
Peer Median
22.60
11.16
-14.65
108.09
--
Net Profit Growth

6.33

Lower than Peers by 16.96

Year on year growth in profit after tax

Company Name
Mar-25
Mar-24
Mar-23
Mar-22
Mar-21
Clinitech Laboratory
6.33
-39.46
19.61
27.39
--
Peer Median
23.29
9.39
-16.12
151.45
--
EPS Growth

-21.73

Lower than Peers by 51.16

Year on year growth in earnings per share

Company Name
Mar-25
Mar-24
Mar-23
Mar-22
Mar-21
Clinitech Laboratory
-21.73
-45.94
19.61
27.37
--
Peer Median
29.43
-7.32
-35.05
150.72
--
Book Value Growth

148.87

--

Year on year growth in book value per share

Company Name
Mar-25
Mar-24
Mar-23
Mar-22
Mar-21
Clinitech Laboratory
148.87
49.03
28.82
32.93
--
Peer Median
--
--
--
--
--

Solvency

View Detailed Peer Comparison

Debt to Equity

--

--

Total debt / Net worth

Company Name
Mar-25
Mar-24
Mar-23
Mar-22
Mar-21
Clinitech Laboratory
--
0.24
0.43
0.48
0.39
Peer Median
0.05
0.08
0.15
0.03
--
Short term debt to equity ratio

--

--

(Short term borrowings / Net worth)

Company Name
Mar-25
Mar-24
Mar-23
Mar-22
Mar-21
Clinitech Laboratory
--
0.16
0.28
0.25
0.00
Peer Median
--
--
--
--
--
Current Ratio

4.36

Higher than Peers by 1.94

Current Assets / Current Liabilities and Provisions

Company Name
Mar-25
Mar-24
Mar-23
Mar-22
Mar-21
Clinitech Laboratory
4.36
1.66
1.12
1.02
2.13
Peer Median
2.42
2.28
1.88
2.40
--
Quick Ratio

4.05

Higher than Peers by 1.68

(Current Assets - Inventory) / Current Liabilities and Provisions

Company Name
Mar-25
Mar-24
Mar-23
Mar-22
Mar-21
Clinitech Laboratory
4.05
1.49
1.04
0.90
2.01
Peer Median
2.37
2.33
1.78
3.09
--
Interest Coverage

11.07

Higher than Peers by 3.45

Earning before interest and taxes (EBIT) / Interest Expenses

Company Name
Mar-25
Mar-24
Mar-23
Mar-22
Mar-21
Clinitech Laboratory
11.07
6.46
13.37
13.15
7.82
Peer Median
7.61
10.16
11.52
12.12
--

Operating Efficiency

View Detailed Peer Comparison

Debtors to sales

18.72

Higher than Peers by 8.10

Debtors outstanding / Net Sales * 100

Company Name
Mar-25
Mar-24
Mar-23
Mar-22
Mar-21
Clinitech Laboratory
18.72
9.34
7.70
5.71
12.26
Peer Median
10.62
7.60
14.45
9.16
--
Asset Turnover

1.03

Higher than Peers by 0.22

Sales / Average Total Assets

Company Name
Mar-25
Mar-24
Mar-23
Mar-22
Mar-21
Clinitech Laboratory
1.03
1.13
1.34
2.05
1.72
Peer Median
0.81
0.77
0.86
1.18
--
Receivable days

47.42

--

Average Debtors / Sales * 365

Company Name
Mar-25
Mar-24
Mar-23
Mar-22
Mar-21
Clinitech Laboratory
47.42
30.99
24.53
26.37
44.75
Peer Median
--
--
--
--
--
Inventory Days

18.01

--

Average Inventory / Sales * 365

Company Name
Mar-25
Mar-24
Mar-23
Mar-22
Mar-21
Clinitech Laboratory
18.01
12.12
8.54
7.00
7.14
Peer Median
--
--
--
--
--
Payable days

113.97

--

Average Creditors / Cost of goods sold * 365

Company Name
Mar-25
Mar-24
Mar-23
Mar-22
Mar-21
Clinitech Laboratory
113.97
123.30
143.70
123.36
164.86
Peer Median
--
--
--
--
--
Cash Conversion Cycle

-48.54

--

Receivable Days + Inventory Days - Payable Days

Company Name
Mar-25
Mar-24
Mar-23
Mar-22
Mar-21
Clinitech Laboratory
-48.54
-80.19
-110.63
-89.98
-112.97
Peer Median
--
--
--
--
--

Valuation

View Detailed Peer Comparison

Price / Earnings

23.27

Lower than Peers by 36.21

Current share price divided by earning per share in the last twelve months

Company Name
Mar-25
Mar-24
Mar-23
Mar-22
Mar-21
Clinitech Laboratory
23.27
--
--
--
--
Peer Median
59.48
60.28
46.86
69.67
--
Price / Book Value

1.04

Lower than Peers by 8.59

Current share price divided by book value per share in the latest financial year

Company Name
Mar-25
Mar-24
Mar-23
Mar-22
Mar-21
Clinitech Laboratory
1.04
--
--
--
--
Peer Median
9.63
8.84
6.59
10.70
--
Dividend Yield

--

--

Dividend per share in the past twelve months divided by current share price

Company Name
Mar-25
Mar-24
Mar-23
Mar-22
Mar-21
Clinitech Laboratory
--
--
--
--
--
Peer Median
0.04
0.42
0.38
0.06
--
EV/EBITDA

5.77

Lower than Peers by 42.40

Enterprise Value (Current Market Capitalisation + Total Debt - Cash & Equivalents) / Earnings before interest, taxes, depreciation and taxes (EBITDA)

Company Name
Mar-25
Mar-24
Mar-23
Mar-22
Mar-21
Clinitech Laboratory
5.77
1.78
1.27
2.00
1.01
Peer Median
48.17
47.88
27.71
45.91
--
Market Cap

9

Lower than Peers by 8,613

Current Share price multiplied by latest total number of shares outstanding

Company Name
Mar-25
Mar-24
Mar-23
Mar-22
Mar-21
Clinitech Laboratory
9
--
--
--
--
Peer Median
8,622
9,694
5,629
5,992
--
loading...
loading...
loading...